We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
-3.13%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$801B
AUM Growth
-$29.1B
Cap. Flow
+$16.3B
Cap. Flow %
2.03%
Top 10 Hldgs %
24.5%
Holding
5,100
New
137
Increased
3,082
Reduced
1,102
Closed
125

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.3B
2
MSFT icon
Microsoft
MSFT
+$1.3B
3
AMD icon
Advanced Micro Devices
AMD
+$925M
4
SPGI icon
S&P Global
SPGI
+$894M
5
TSLA icon
Tesla
TSLA
+$716M

Sector Composition

Rank Sector Weight
1 Technology 25.39%
2 Financials 13.32%
3 Healthcare 13.3%
4 Consumer Discretionary 11.44%
5 Communication Services 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEPH icon
4826
Nephros
NEPH
$36.8M
$44K ﹤0.01%
+10,192
New +$48.4K
NUWE icon
4827
Nuwellis
NUWE
$160K
0
DYNT
4828
DELISTED
Dynatronics Corp
DYNT
$44K ﹤0.01%
12,232
APTO
4829
DELISTED
Aptose Biosciences, Inc.
APTO
$44K ﹤0.01%
72
CNSP icon
4830
CNS Pharmaceuticals
CNSP
$8.51M
0
GAME icon
4831
GameSquare
GAME
$34.6M
$43K ﹤0.01%
5,890
GLMD icon
4832
Galmed Pharmaceuticals
GLMD
$5.13M
$43K ﹤0.01%
151
SDEV
4833
Stablecoin Development Corp
SDEV
$58M
$43K ﹤0.01%
24
XNET
4834
Xunlei
XNET
$340M
$43K ﹤0.01%
24,768
AUVI
4835
DELISTED
Applied UV, Inc. Common Stock
AUVI
$43K ﹤0.01%
233
MDNA
4836
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$43K ﹤0.01%
34,144
+6,511
+24% +$10.1K
DPRO
4837
Draganfly
DPRO
$153M
$42K ﹤0.01%
+720
New +$26.6K
FGNX
4838
FG Nexus Inc
FGNX
$41.6M
$42K ﹤0.01%
131
MSGM icon
4839
Motorsport Games
MSGM
$18.1M
$42K ﹤0.01%
3,228
AYLA
4840
DELISTED
Ayala Pharmaceuticals, Inc. Common Stock
AYLA
$42K ﹤0.01%
+10,596
New +$55.1K
RHE
4841
DELISTED
Regional Health Properties, Inc.
RHE
$42K ﹤0.01%
12,145
TENX icon
4842
Tenax Therapeutics
TENX
$363M
$41K ﹤0.01%
32
TOPS icon
4843
TOP Ships
TOPS
$3.49M
$41K ﹤0.01%
167
STAB
4844
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$41K ﹤0.01%
130,774
ZSTK
4845
ZeroStack Corp
ZSTK
$3.69M
$40K ﹤0.01%
26
GRI
4846
GRI Bio
GRI
$2.44M
0
NMTC icon
4847
NeuroOne Medical Technologies
NMTC
$14.7M
$40K ﹤0.01%
+6,208
New +$75.2K
SIFY
4848
Sify Technologies
SIFY
$1.06B
$40K ﹤0.01%
2,284
ATXI
4849
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
$40K ﹤0.01%
75
+6
+9% +$4.49K
AKU
4850
DELISTED
Akumin Inc
AKU
$40K ﹤0.01%
36,627

Similar funds

Geode Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Geode Capital Management held 5,100 positions worth $801B, down 3.5% from $830B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Geode Capital Management's Q1 2022 filing shows 137 new, 3,082 increased, 1,102 reduced and 125 closed positions. Its largest new stake was Constellation Energy: 5,541,478 shares worth $311M. The largest sale was Xilinx Inc, an estimated $1.08B.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q1 2022 buy was Constellation Energy: 5,541,478 shares worth $311M.
  • Geode Capital Management added most to Apple in Q1 2022, an estimated $1.3B increase.
  • Geode Capital Management's biggest Q1 2022 reduction was Merck, cutting an estimated $295M.
  • Geode Capital Management fully exited Xilinx Inc in Q1 2022, selling an estimated $1.08B.
  • Geode Capital Management's ten largest holdings make up 24% of its $801B portfolio in Q1 2022.
  • Geode Capital Management opened 137 new positions and closed 125 in Q1 2022.
  • Geode Capital Management's portfolio value fell 3.5% quarter-over-quarter to $801B.

Based on Geode Capital Management's 13F filing for Q1 2022, filed 13 May 2022.